Familial paraganglioma: a novel presentation of a case and response to therapy with radiolabelled MIBG.

Familial paraganglioma: a novel presentation of a case and response to therapy with radiolabelled MIBG.

Phaeochromocytomas (PC) and paragangliomas are disorders of the sympatho-adrenomedullary system. They are chromaffin-containing neuroendocrine tumors of neural crest origin that contain catecholamine-secreting granules: they arise from either the adrenal medulla (phaeochromocytomas) or from extra-ad...

Full description

Bibliographic Details
Main Authors:	Lawrence, J, Maher, E, Sheaves, R, Grossman, AB
Format:	Journal article
Language:	English
Published:	2004

Similar Items

The value of radiolabelled MIBG and octreotide in the diagnosis and management of neuroendocrine tumours.
by: Kaltsas, G, et al.
Published: (2001)

Treatment of metastatic pheochromocytoma and paraganglioma with I-131-meta-iodobenzylguanidine (MIBG)
by: Kaltsas, G, et al.
Published: (2003)

The clinical presentation (symptoms and signs) of sporadic and familial chromaffin cell tumours (phaeochromocytomas and paragangliomas).
by: Kaltsas, G, et al.
Published: (2004)

Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies.
by: Nölting, S, et al.
Published: (2012)

Peptide Receptor Radionuclide Treatment and (131)I-MIBG in the management of patients with metastatic/progressive phaeochromocytomas and paragangliomas
by: Nastos, K, et al.
Published: (2017)

Familial paraganglioma syndromes.
by: Chetty, R
Published: (2010)

Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].
by: Mukherjee, J, et al.
Published: (2001)

Sequelae and survivorship in patients treated with (131)I-MIBG therapy.
by: Sze, W, et al.
Published: (2013)

Sequelae and survivorship in patients treated with 131 I-MIBG therapy
by: Sze, W, et al.
Published: (2013)

A Rare Case of Presacral Paraganglioma Presenting with Hypertensive Encephalopathy
by: Dhiraj KB.,, et al.
Published: (2015)

Pheochromocytomas and paragangliomas: assessment of malignant potential.
by: Korevaar, T, et al.
Published: (2011)

Pheochromocytomas and paragangliomas: assessment of malignant potential
by: Korevaar, T, et al.
Published: (2011)

The management of head-and-neck paragangliomas.
by: Capatina, C, et al.
Published: (2013)

Familial prolactinoma and paraganglioma: A new clinical entity?
by: Walker, L, et al.
Published: (2005)

The diagnosis and management of malignant phaeochromocytoma and paraganglioma.
by: Chrisoulidou, A, et al.
Published: (2007)

MIBG scans for phaeochromocytoma: time to abandon the technique?
by: Grossman, A, et al.
Published: (2009)

Radionuclide treatment of neuroendocrine tumours with the novel radiolabelled analogue Y-90-SMT 487
by: Carroll, P, et al.
Published: (2003)

Carcinoid tumours presenting as breast cancer: the utility of radionuclide imaging with 123I-MIBG and 111In-DTPA pentetreotide.
by: Kaltsas, G, et al.
Published: (1998)

Multimodality palliative treatment of (111)In-pentetreotide negative/(123)I-MIBG positive metastatic carcinoid - a case report.
by: Dworakowska, D, et al.
Published: (2008)

Novel methods for 18F-radiolabelling
by: Calderwood, S
Published: (2016)

A legacy of tinnitus: multiple head and neck paragangliomas.
by: Tan, T, et al.
Published: (2009)

Naloxone provokes catecholamine release in phaeochromocytomas and paragangliomas.
by: Bouloux, P, et al.
Published: (1986)

Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B (SDH-B) gene mutation carriers.
by: Srirangalingam, U, et al.
Published: (2008)

Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues.
by: Kaltsas, G, et al.
Published: (2005)

CT and MR imaging of unusual locations of extra-adrenal paragangliomas (pheochromocytomas).
by: Sahdev, A, et al.
Published: (2005)

Dandy-Walker malformation, papillary thyroid carcinoma, and SDHD-associated paraganglioma syndrome.
by: Huguet, I, et al.
Published: (2013)

Hepatobiliary and Pancreatic: A huge liver paraganglioma
by: Koh, P.S., et al.
Published: (2013)

Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
by: Fishbein, Lauren, et al.
Published: (2018)

Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
by: Astuti, D, et al.
Published: (2003)

Targeting telomerase with radiolabeled inhibitors.
by: Waghorn, P, et al.
Published: (2016)

123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation.
by: Bhatia, K, et al.
Published: (2008)

Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidine.
by: Bomanji, J, et al.
Published: (1993)

Current management of pheochromocytoma/paraganglioma: a guide for the practicing clinician in the era of precision medicine
by: Nölting, S, et al.
Published: (2019)

An undiagnosed non functioning retroperitoneum paraganglioma, complicating a gynaecological surgery; a case report
by: Abd. Wahab, Noraziana, et al.
Published: (2010)

Routine preoperative (123)I-MIBG scintigraphy for patients with phaeochromocytoma is not necessary.
by: Mihai, R, et al.
Published: (2008)

18F-radiolabeling of aryl derivatives
by: Gouverneur, V
Published: (2012)

New methods for F-18 radiolabelling
by: Szpera, R
Published: (2021)

Radiolabelled copper complexes for cancer imaging
by: Hueting, R
Published: (2011)

Gangliocytic paraganglioma: a rare case with metastases of all 3 elements to liver and lymph nodes.
by: Rowsell, C, et al.
Published: (2011)

Imaging neuroendocrine tumours with radiolabelled somatostatin analogues and X-ray computed tomography: a comparative study.
by: King, C, et al.
Published: (1993)